IL1B and age-related macular degeneration: As mentioned, there is now a selective Il-1 beta inhibitor which has shown a mortality benefit in cardiovascular disease, and these data as well as the notable similarities between the two diseases raise the prospect of Il-1 beta modulation as therapy for AMD.